sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals MEA Respiratory Tract Infection Treatment Market...

MEA 호흡기 감염 치료 시장 규모 및 예측(2021~2031년), 지역 점유율, 추세 및 성장 기회 분석 보고서 범위: 약물별(항생제, NSAID, 기침 억제제, 코 충혈 완화제 및 기타), 질병 적응증(상부 호흡 기관) 감염 및 하부 호흡기 감염), 투여 경로(경구 및 비경구), 연령군(소아 및 성인), 유통 경로(병원 약국, 온라인 약국, 소매 약국) 및 국가

BMIRE00030044 | Pages: 201 | Pharmaceuticals | Mar 2024 | Type: Regional | Status: Published
MEA 호흡기 감염 치료제 시장 규모는 2023년 20억 9천만 달러에서 2031년 29억 7천만 달러로 성장할 것으로 예상됩니다. 2023년부터 2031년까지 연평균 성장률(CAGR)은 4.50%로 예상됩니다. 호흡기 감염 치료를 위한 OTC 제품에 대한 수요 급증 MEA 호흡기 감염 치료 시장 성장 기회 수많은 소비자가 다음과 같은 일반적인 호흡기 증상에 대한 접근 가능하고 편리한 솔루션을 찾고 있습니다. 기침, 코막힘, 인후통 등이 있습니다. 이 접근 방식은 생명을 위협하는 질병을 앓고 있지 않은 개인이 자신의 건강을 면밀히 모니터링하고 통제할 수 있는 권한을 부여합니다. 또한 이를 통해 제조업체, 약국 및 의료 서비스 제공자는 일반의약품(OTC) 애플리케이션에 더욱 적합한 제품을 만들고, 소비자에게 자가 관리 방법을 교육하고, 다양한 증상 완화를 제공하는 치료 옵션에 대한 접근성을 향상시킬 수 있습니다. OTC 호흡기 치료제의 급증하는 인기는 호흡기 건강 인식 제고, 자가 관리 전략 육성 및 협력적인 의료 생태계의 중요성을 강조합니다. OTC 호흡기 제품의 인기 상승을 활용하여 MEA의 호흡기 감염 치료 시장 이해관계자는 환자 참여를 강화하고 예방 의료 조치를 촉진하며 다양한 인구의 진화하는 의료 요구를 해결할 수 있습니다. 따라서 호흡기 감염 관리를 위한 OTC 제품에 대한 수요 증가는 MEA 호흡기 감염 치료 시장에 중요한 기회를 의미합니다. 약물 기반 통찰력 약물 측면에서 항생제 부문은 2023년에 가장 큰 MEA 호흡기 감염 치료 시장 점유율을 차지했습니다. 이는 2023~2031년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 호흡기 감염에는 기관지염, 폐렴, 부비동염 등 다양한 질병이 포함되며, 종종 세균성 병원체에 의해 발생합니다. 질병 표시 기반 통찰력 질병 표시를 기반으로 하기도 감염 부문은 2023년에 더 큰 시장 점유율을 차지했습니다. 또한 2023년부터 2031년까지 더 높은 CAGR을 등록할 것으로 예상됩니다. 하기도 감염(LRTI)은 다음과 같은 영향을 미치는 감염입니다. 일반적으로 박테리아, 바이러스 또는 곰팡이 병원체에 의해 발생하는 폐 및 기관지. 투여 경로 기반 통찰력 투여 경로에 따라 경구 부문은 MEA 호흡기 감염 치료 시장에서 더 큰 점유율을 차지했습니다. 동일한 부문은 2023~2031년 동안 더 높은 CAGR을 기록할 것으로 예상됩니다. 아목시실린, 아지스로마이신, 독시사이클린과 같은 경구 항생제는 호흡기 감염을 일으키는 세균성 병원체와 싸우기 위해 자주 처방됩니다. 연령 그룹 기반 통찰력 연령 그룹 측면에서 성인 부문은 2023년 MEA 호흡기 감염 치료 시장에서 더 큰 점유율을 차지했습니다. 소아 부문은 2023~2031년 동안 더 높은 CAGR을 기록할 것으로 예상됩니다. 어린이들 사이에서 호흡기 감염의 높은 유병률은 효과적인 치료 옵션의 필요성을 높이는 핵심 요소입니다. 유통 채널 기반 통찰력 유통 채널 측면에서 병원 약국 부문은 2023~2031년 동안 상당한 시장 점유율을 차지할 것으로 예상됩니다. 병원 약국은 의료 시스템의 핵심 구성 요소 역할을 합니다. 특히 정맥이나 근육 내 약물 투여가 필요한 급성 및 중증 호흡기 감염 관리에 중요한 역할을 합니다. MEA 호흡기 감염 치료 시장에 대한 보고서를 준비하는 동안 언급된 주요 1차 및 2차 소스로는 두바이 보건 당국, 사우디 천식 이니셔티브, 사우디 흉부 학회 등이 있습니다.
Table of Contents

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Respiratory Tract Infection Treatment Market Landscape

4.1 Overview

4.2 PEST Analysis

5. MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics

5.1 MEA Respiratory Tract Infection Treatment Market - Key Market Dynamics

5.2 Key Market Drivers

5.2.1 Rising Cases of Respiratory Infections in Middle East

5.2.2 Increasing Awareness Related to Respiratory Tract Infections

5.3 Key Market Restraints

5.3.1 Lack of Research Focused on Respiratory Therapeutics

5.4 Key Market Opportunities

5.4.1 Surge in Demand for OTC Products to Treat Respiratory Infections

5.5 Future Trends

5.5.1 Advent of Antiviral Treatment for MERS

5.6 Impact of Drivers and Restraints:

6. MEA Respiratory Tract Infection Treatment Market Analysis

6.1 MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031

7. MEA Respiratory Tract Infection Treatment Market Analysis - by Drugs

7.1 Antibiotics

7.1.1 Overview

7.1.2 Antibiotics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

7.2 NSAIDs

7.2.1 Overview

7.2.2 NSAIDs: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Cough Suppressants

7.3.1 Overview

7.3.2 Cough Suppressants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

7.4 Nasal Decongestants

7.4.1 Overview

7.4.2 Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8. MEA Respiratory Tract Infection Treatment Market Analysis - by Disease Indication

8.1 Lower Respiratory Tract Infection

8.1.1 Overview

8.1.2 Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8.2 Upper Respiratory Tract Infection

8.2.1 Overview

8.2.2 Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9. MEA Respiratory Tract Infection Treatment Market Analysis - by Route Of Administration

9.1 Oral

9.1.1 Overview

9.1.2 Oral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Parenteral

9.2.1 Overview

9.2.2 Parenteral: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10. MEA Respiratory Tract Infection Treatment Market Analysis - by Age Group

10.1 Pediatrics

10.1.1 Overview

10.1.2 Pediatrics: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10.2 Adults

10.2.1 Overview

10.2.2 Adults: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11. MEA Respiratory Tract Infection Treatment Market Analysis - by Distribution Channel

11.1 Hospital Pharmacies

11.1.1 Overview

11.1.2 Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11.2 Retail Pharmacies

11.2.1 Overview

11.2.2 Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Online Pharmacies

11.3.1 Overview

11.3.2 Online Pharmacies: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12. MEA Respiratory Tract Infection Treatment Market - Country Analysis

12.1 Middle East and Africa

12.1.1 MEA Respiratory Tract Infection Treatment Market Breakdown by Countries

12.1.2 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country

12.1.3 MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030

12.1.3.1 MEA Respiratory Tract Infection Treatment Market Revenue and Forecast and Analysis - by Country

12.1.3.2 Saudi Arabia

12.1.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.3.1 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.3.2 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.3.3 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.3.4 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.3.5 Saudi Arabia: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

12.1.3.4 South Africa

12.1.3.5 South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.5.1 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.5.2 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.5.3 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.5.4 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.5.5 South Africa: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

12.1.3.6 UAE

12.1.3.7 UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.7.1 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.7.2 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.7.3 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.7.4 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.7.5 UAE: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

12.1.3.8 Rest of MEA

12.1.3.9 REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

12.1.3.9.1 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Drugs

12.1.3.9.2 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Disease Indication

12.1.3.9.3 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Route Of Administration

12.1.3.9.4 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Age Group

12.1.3.9.5 REST of MEA: MEA Respiratory Tract Infection Treatment Market Breakdown by Distribution Channel

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Teva Pharmaceutical Industries Ltd

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Sanofi SA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boehringer Ingelheim International GmbH

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 AstraZeneca Plc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Alembic Pharmaceuticals Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 GSK Plc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Novartis AG

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 F. Hoffmann-La Roche Ltd

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gulf Pharmaceutical Industries Co

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

List of TablesTable 1. MEA Respiratory Tract Infection Treatment Market Segmentation

Table 2. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 3. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 4. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 5. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 6. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 7. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Country

Table 8. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 9. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 10. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 11. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 12. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 13. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 14. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 15. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 16. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 17. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 18. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 19. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 20. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 21. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 22. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 23. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Drugs

Table 24. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Indication

Table 25. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration

Table 26. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Age Group

Table 27. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel

Table 28. Glossary of Terms, MEA Respiratory Tract Infection Treatment Market

List of Figures

Figure 1. MEA Respiratory Tract Infection Treatment Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. MEA Respiratory Tract Infection Treatment Market Revenue (US$ Million), 2023-2031

Figure 5. MEA Respiratory Tract Infection Treatment Market Share (%) - by Drugs, 2023 and 2031

Figure 6. Antibiotics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 7. NSAIDs: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 8. Cough Suppressants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 9. Nasal Decongestants: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 10. MEA Respiratory Tract Infection Treatment Market Share (%) - by Disease Indication, 2023 and 2031

Figure 11. Lower Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 12. Upper Respiratory Tract Infection: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 13. MEA Respiratory Tract Infection Treatment Market Share (%) - by Route Of Administration, 2023 and 2031

Figure 14. Oral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 15. Parenteral: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 16. MEA Respiratory Tract Infection Treatment Market Share (%) - by Age Group, 2023 and 2031

Figure 17. Pediatrics: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 18. Adults: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 19. MEA Respiratory Tract Infection Treatment Market Share (%) - by Distribution Channel, 2023 and 2031

Figure 20. Hospital Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 21. Retail Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 22. Online Pharmacies: MEA Respiratory Tract Infection Treatment Market- Revenue and Forecast to 2031 (US$ Million)

Figure 23. MEA Respiratory Tract Infection Treatment Market Breakdown by Key Countries, 2023 and 2031 (%)

Figure 24. MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2030(US$ Million)

Figure 25. Saudi Arabia: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

Figure 26. South Africa: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. UAE: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. REST of MEA: MEA Respiratory Tract Infection Treatment Market - Revenue and Forecast to 2031 (US$ Million)

The List of Companies - MEA Respiratory Tract Infection Treatment Market

  • Abbott Laboratories

  • AstraZeneca plc

  • Alembic Pharmaceuticals Ltd.

  • Boehringer Ingelheim International GmbH

  • GlaxoSmithKline plc

  • Teva Pharmaceutical Industries Ltd

  • Novartis AG

  • F. Hoffmann-La Roche AG

  • Sanofi S.A.

  • Orion Corporation

  • Julphar
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA Respiratory Tract Infection Treatment Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA Respiratory Tract Infection Treatment Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the MEA Respiratory Tract Infection Treatment Market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports
    Report Name Published Date
    MEA Logistics Market Forecast to 2028 -COVID-19 Impact and Analysis by Model (1PL, 2PL, 3PL, 4PL, Cold Chain, Secure Logistics, and Last Mile Delivery.. Apr 2022
    MEA N95 Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (With Exhalation Valve and Without Exhalation Valve), Distrib.. Oct 2021
    Middle East and Africa Variable Speed Drive Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Voltage (Low Voltage and Medium Voltage.. Sep 2021
    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440
    GET FREE SAMPLE PDF
    Inquire before Buying Inquire for Discount
    Subscription Member Price: FREE
    Get Subscription